Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Lidocaine via a feeding tube to prevent nausea after bariatric surgery

Official title: Effect of Lidocaine Applied Via Nasogastric Tube on Postoperative Nausea and Vomiting in Obese Patients Undergoing Bariatric Surgery

Run by General Hospital of Ningxia Medical University · NCT07643298 · Data updated 2026-11-12

This trial tests whether giving lidocaine through a stomach tube at the end of laparoscopic sleeve gastrectomy reduces nausea and vomiting in adults with obesity.

More PONV trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorGeneral Hospital of Ningxia Medical University
Academic / other
Locations1 site (Yinchuan, Ningxia)
StatusRecruiting
StartedMay 20, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJune 11, 2026
Trial IDNCT07643298 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-65 with ASA II-III scheduled for primary elective laparoscopic sleeve gastrectomy and able to consent.

Probably not a fit

Patients who do not respond to lidocaine exposure or who have contraindications may not experience a reduction in PONV.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18-65 undergoing primary laparoscopic sleeve gastrectomy are randomly assigned to receive either 0.5% lidocaine (20 ml) or normal saline (20 ml) through an orogastric tube after surgery and before extubation. The gastric tube is clamped for 5 minutes to allow mucosal exposure, and patients receive standardized anesthesia and perioperative care. PONV will be tracked in the post-anesthesia care unit and for the first 24 hours postoperatively to determine if lidocaine lowers incidence. The study builds on evidence of lidocaine’s anti-inflammatory and analgesic effects that may influence GI function and vomiting pathways. Overall, the trial examines a simple, inexpensive intervention to reduce a common bariatric complication.

Why it matters

Potential benefit: If successful, patients may experience fewer episodes of postoperative nausea and vomiting and a smoother early recovery.

How similar studies have gone: Previous perioperative lidocaine findings suggest potential GI benefits, but this specific intragastric approach for PONV prevention is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged between 18 and 65 years old;
* American Society of Anesthesiologists (ASA) physical status classification II - III;
* Planned to undergo primary elective laparoscopic sleeve gastrectomy with general anesthesia;
* Capable of giving informed consent.

Exclusion Criteria:

* Known allergy, hypersensitivity or contraindication to lidocaine or amide - type local anesthetics;
* Previous significant liver or kidney dysfunction (e.g., ALT/AST \> 3 times the upper limit of normal, GFR \< 30 mL/min);
* History of epilepsy, cardiac conduction abnormalities or previous diagnosis of malignant hyperthermia;
* Pregnancy or lactation;
* Patients who received systemic lidocaine treatment during the operation;
* History of severe postoperative nausea and vomiting (PONV) or motion sickness, requiring multiple prophylactic medications;
* Emergency or revision bariatric surgery.

Where it's running

  • General Hospital of Ningxia Medical University
    Yinchuan, Ningxia, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.